Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy
Advantages of polymeric nanoparticles as drug delivery systems include controlled release, enhanced drug stability and bioavailability, and specific tissue targeting. Nanoparticle properties such as hydrophobicity, size, and charge, mucoadhesion, and surface ligands, as well as administration route and suspension media affect their ability to overcome ocular barriers and distribute in the eye, and must be carefully designed for specific target tissues and ocular diseases. This review seeks to discuss the available literature on the biodistribution of polymeric nanoparticles and discuss the effects of nanoparticle composition and administration method on their ocular penetration, distribution, elimination, toxicity, and efficacy, with potential impact on clinical applications.
Publication Source (Journal or Book title)
Journal of nanobiotechnology
Swetledge, S., Jung, J. P., Carter, R., & Sabliov, C. (2021). Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy. Journal of nanobiotechnology, 19 (1), 10. https://doi.org/10.1186/s12951-020-00745-9